GlassScriptPhysician profile
Ashlin Kocan
NPI 1326647157
$1,395.04
in general payments reported to CMS, 2019-2025
12 companies · $662 in 2025
The $662 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $173 · 2022: $240 · 2023: $112 · 2024: $209 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $429.16 | 2022-2025 | Preveleak, Perclot |
| Janssen Pharmaceuticals, INC | $220.70 | 2021-2022 | |
| Pfizer INC. | $159.87 | 2021-2024 | |
| Medtronic, INC. | $134.20 | 2025 | Heli-Fx Endoanchor System |
| Haemonetics Corporation | $113.65 | 2024 | Teg6s Hemostasis System |
| Solventum Corporation | $88.10 | 2024-2025 | Abthera, Activ.A.C., V.A.C. Veraflo |
| Heron Therapeutics, INC. | $61.51 | 2023 | Zynrelef |
| Davol INC. | $59.69 | 2025 | Phasix Mesh, Arista |
| Smith+Nephew, INC. | $45.42 | 2025 | Pico 7, Pico 14, Renasys Touch |
| Kerecis Limited | $34.18 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Mimedx Group, INC. | $24.36 | 2025 | |
| Integra Lifesciences Corporation | $24.20 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlin Kocan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.